Back to search

Belgium· BE-AMP-SAM124801-00

Prostin VR 0.5 mg/ml

A alprostadil product containing alprostadil, registered in Belgium by Pfizer. The same ATC class is registered in 10 of our 19 countries.

ATC C01EA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedProstin VR 0.5 mg/mlATCC01EA01REGISTER NO.BE-AMP-SAM124801-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Alprostadil is registered in 10 of 19 countries.

Countries holding a registration under ATC C01EA01 (alprostadil), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Alprostadil · ATC C01EA01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Alprostadil
Manufacturer
Pfizer
Country
Belgium (BE)
ATC code
C01EA01
ATC class
Alprostadil
Defined daily dose
0.5 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0715961
  • be_apb
    0892273

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for alprostadil.

Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alprostadil · interactions on record

84 records

  • 22 moderate
  • 62 info

Most severe, free to view

  • LorcaserinA08AA11moderate
  • DapagliflozinA10BK01moderate
  • CanagliflozinA10BK02moderate
  • EmpagliflozinA10BK03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alprostadil in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alprostadil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Alprestil, Alprostadil Altan
  • Bulgaria · Алпростадил Ромфарм, Проставазин
  • Cyprus · Caverject, Vitaros
  • Czechia · Alprostan, Karon
  • Germany · Alprostadil Altan, Caverject
  • Denmark · Caverject Dual, Muse
  • Estonia · Muse, Neupedix
  • Spain · Alprostadil Altan, Alprostadil Pfizer
  • Finland · Caverject Dual, Muse
  • France · Alprostadil Intsel Chimos, Alprostadil Oresund Pharma
  • United Kingdom (Northern Ireland) · Alprostadil Pfizer, Caverject
  • Greece · Caverject, Prostin Vr
  • Croatia · Prostin Vr
  • Hungary · Alprestil, Alprostadil Altan
  • Ireland · Caverject, Vitaros
  • Iceland · Caverject Dual, Vitaros
  • Italy · Alprostar, Caverject
  • Lithuania · Muse, Neupedix
  • Luxembourg · Caverject, Prostavasin
  • Latvia · Muse, Neupedix
  • Malta · Caverject
  • Netherlands · Alprostadil Recordati, Alprostadil Simple Pharma
  • Norway · Bondil, Caverject Dual
  • Poland · Prostavasin 60, Prostin Vr
  • Portugal · Caverject, Muse
  • Romania · Alprostadil Remedia, Alprostadil Rompharm
  • Sweden · Bondil, Caverject Dual
  • Slovenia · Alprostin Vr, Caverject
  • Slovakia · Alprostan, Alprostapint

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e529dff1-5036-4fcc-b388-2f2c43e154ed
GET /v1/drugs/e529dff1-5036-4fcc-b388-2f2c43e154ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Prostin VR 0.5 mg/ml",
  "name_fr": "Prostin VR 0.5 mg/ml",
  "name_nl": "Prostin VR 0.5 mg/ml",
  "amp_code": "SAM124801-00",
  "strengths": [
    "0.5000",
    "0.8000"
  ],
  "pack_count": 1,
  "substances": [
    "Alprostadil",
    "Anhydrous Ethanol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Alprostadil",
  "authorisation_numbers": [
    "BE124801"
  ]
}

See everything about alprostadil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.